If your only tool is a hammer, everything looks like a nail. Such was the state of the pharmaceutical industry a decade ago. Gone are the days of pharmaceutical companies predominantly specializing in single modalities such as traditional vaccines, monoclonal antibodies, plasma-derived therapies or small molecules. Today’s Big Pharma, fueled by the acquisition of countless…

I have young kids. That means I’m often immersed in the land of make-believe, where anything is possible, and animals have magical powers. Lately, I’ve noticed that my kids’ world has more in common with the reality of life science R&D than ever before. Anything is becoming possible in terms of drug discovery and development…